Stock listing

BIOA Stock Price, News, Filings & Events — Bioage Labs, Inc.

Selected listing: BIOA · BOATS · USD · US

This page tracks Bioage Labs, Inc.'s BIOA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOA:BOATS. BIOA:BOATS is the stock-level entry point for investors researching Bioage Labs, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioage Labs, Inc. is a public company traded under the ticker BIOA on the American market. The company has a market capitalization of approximately $1.08 billion. Bioage Labs focuses on developing therapies to extend healthy lifespan and address age-related diseases.

BIOA:BOATSUSDUSUpdated August 31, 2026
Bioage Labs, Inc. logo
Ticker
BIOA:BOATS
Asset type
Stock
Market cap
$1.10B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Bioage Labs, Inc. BIOA:BOATS stock context

This page tracks Bioage Labs, Inc.'s BIOA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOA:BOATS. BIOA:BOATS is the stock-level entry point for investors researching Bioage Labs, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioage Labs, Inc. is a public company traded under the ticker BIOA on the American market. The company has a market capitalization of approximately $1.08 billion. Bioage Labs focuses on developing therapies to extend healthy lifespan and address age-related diseases.

Latest news from Bioage Labs, Inc.

All Bioage Labs, Inc. news →

Research Bioage Labs, Inc.

Alternate listings